Skip to Content

Drug interactions between BuSpar and calcium carbonate / famotidine / magnesium hydroxide

Results for the following 2 drugs:
BuSpar (buspirone)
calcium carbonate/famotidine/magnesium hydroxide

Interactions between your drugs

There were no interactions found in our database between BuSpar and calcium carbonate / famotidine / magnesium hydroxide - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.


A total of 824 drugs (4389 brand and generic names) are known to interact with BuSpar.

calcium carbonate / famotidine / magnesium hydroxide

A total of 724 drugs (3661 brand and generic names) are known to interact with calcium carbonate / famotidine / magnesium hydroxide.

  • Calcium carbonate / famotidine / magnesium hydroxide is a member of the drug class H2 antagonists.
  • Calcium carbonate / famotidine / magnesium hydroxide is used to treat GERD.

Drug and food interactions


busPIRone food

Applies to: BuSpar (buspirone)

You should avoid the use of alcohol while being treated with busPIRone. Alcohol can increase the nervous system side effects of busPIRone such as dizziness, drowsiness, and difficulty concentrating. Some people may also experience impairment in thinking and judgment. Patients receiving busPIRone should preferably avoid the consumption of large amounts of grapefruits and grapefruit juice. If this is not possible, the busPIRone dose should be taken at least 2 hours before or 8 hours after grapefruit or grapefruit juice. Large amounts of grapefruit and grapefruit juice may cause increased levels of busPIRone in your body. This can lead to increased adverse effects such as drowsiness. Talk to your doctor or pharmacist if you have any questions or concerns.

Switch to professional interaction data

Therapeutic duplication warnings

No therapeutic duplications were found for your selected drugs.

Drug Interaction Classification

The classifications below are a guideline only. The relevance of a particular drug interaction to a specific patient is difficult to determine using this tool alone given the large number of variables that may apply.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.